News & Events > Press Releases
> News & Media
Conferences & Events

February 2015

Medical Device Daily: Israeli imaging companies often must reach maturity to find a proper suitor.

Real Imaging has developed a new system that has the potential to significantly change the world of diagnostic breast imaging.

For more please see: Medical Device Daily

June 2014

Israel 21C: The radiation-free alternative for breast-cancer detection

Real Imaging's no-radiation, no-contact screening device could offer a lifesaving alternative to mammography for millions of women with dense breast tissue.

For more please see:
The radiation-free alternative for breast-cancer detection


May 2014

Real Imaging Receives CE Mark for "Real Imager 8" - Breast Cancer Screening System

Airport City, Israel., May 21, 2014 - Real Imaging Ltd. today announced that it has received CE Mark designation for its Real Imager 8 device intended for use as adjunct breast cancer screening modality. Real Imaging is the first company to introduce an imaging-based risk assessment system that utilizes 3D functional non-invasive metabolic imaging of the breast. The device objectively assess the risk and likelihood that the woman harbors a breast cancer by assessing several imaging biomarkers associated with malignancy.

Read Press Release:
Real Imaging Receives CE Mark for Real Imager 8 Breast Cancer Screening Exam


March 2014

New clinical trial for women at high risk, carriers of BRCA gene mutation, commenced at Sheba's Merav imaging center utilizing Real Imaging's MIRA technology

This clinical trial will form part of a longitudinal multi-center trial for women who are BRCA 1 and BRCA2 carriers. A series of other feasibility-based clinical trials will be conducted as well, including, the efficacy of MIRA technology for women with breast implants

For more please see:
http://www.realimaging.com/Technology/clinical_ongoing.asp


February 2014 (In French)

Publication in the French Silicon Wadi - Cancer du sein : une technologie israélienne pour mieux dépister la maladie

Real Imaging a développé une solution d'imagerie compléte destinée à la détection du cancer du sein.

For more please see:
Une technologie Israélienne pour mieux dépister la maladie


February 2014

Globes: Israel business arena website (Eng version):

This is the first major investment in an Israeli company by the Chinese private equity fund.

Breast cancer diagnostics company Real Imaging Ltd. has raised several million dollars from China Everbright Investment Management Ltd. This is the company's first financing round since the failure of its run as a public company on the Tel Aviv Stock Exchange (TASE), and the first major investment in an Israeli company by the Chinese private equity fund.

For more please see:
China Everbright Ltd. invests in Real Imaging.


February 2014

NoCamels News Flash (All the latest Israel Innovation News): Real Imaging raises Millions from China Everbright Ltd

China Everbright Ltd. invests in Real Imaging.

For more please see:
Real Imaging raises Millions from China Everbright Ltd


December 2013

Real Imaging presentation at RSNA 2013 was selected for publication in the RSNA Bulletin as one of the interesting talks of the conference.

For more please see:
http://rsna2013.rsna.org/dailybulletin/index.cfm?pg=13mon08

And also please read:
RSNA 2013 Bulletin - RealImaging System Aids Breast Cancer Detection


December 2013

Israel 21C: Real Imaging - one of the top 10 medical advances to watch in 2014

ISRAEL21c compiles a list of the 10 most extraordinary medical devices and pharmaceuticals that promise to revolutionize global healthcare.

For more please see:
top 10 israeli medical advances to watch in 2014


September 2013

Real Imaging to commence a clinical trial of its imaging system for early detaction and risk assesment of breast cancer in Karolinska Institute (Stockholm, Sweden)

The clinical trial in Karolinska Institute (Stockholm, Sweden) will commenced in October 2013,as part of a Swedish nation-wide research (KARMA), conducted by that institute. This study is one of the largest breast cancer risk assessment researches to date that has already recruited over 70,000 women. A subset of those women will be screened by Real Imaging's investigational device.

The clinical trial in Karolinska Institute is a two-phase trial and its objective is to demonstrate the efficacy of Real Imaging's MIRA technology as a screening modality adjunct to mammography for women with dense breast tissue.

For more please see:
http://www.realimaging.com/Technology/clinical_ongoing.asp

Medical Device Professionals
Real Imaging's revolutionary breast cancer detection technology...
Read More
Healthcare Community
Help your patients stay healthy with MIRA™
Learn more
Patients and Families
Eliminate your fears of breast cancer
Learn more about
how we can help
© 2017 Real Imaging  ריל אימג'ינג. All Rights Reserved.        Sitemap |  Terms of use  |  Privacy policy Design: Portnov-Mishan    Created By: Foothold Systems Ltd.